CBP Intercepts 13 Tons Of Human Hair From Chinese Prison Camps
U.S. Customs and Border Protection at the Port of New York/Newark seized a shipment of human hair from China suspected of being “forced labor products,” according to a press release.
The packages weighed nearly 13 tons and have an estimated value of over $800,000.
“It is absolutely essential that American importers ensure that the integrity of their supply chain meets the humane and ethical standards expected by the American government and by American consumers,” said Brenda Smith, Executive Assistant Commissioner of the CBP Office of Trade.
Smith added, “The production of these goods constitutes a very serious human rights violation, and the detention order is intended to send a clear and direct message to all entities seeking to do business with the United States that illicit and inhumane practices will not be tolerated in U.S. supply chains.”
The hair came from Lop County Meixin Hair Product Co. Ltd., which is located in China’s Xinjiang region, an area where the Chinese government has imprisoned Uighurs, a Turkic-ethnic minority.
In recent days, the Trump administration has expressed condemnation over reports indicating that Beijing is attempting to control the Uighur population through mass forced sterilization, Intrauterine Contraceptive Devices, and abortions.
According to the AP’s extensive investigation into what some are calling the Chinese government’s genocidal campaign, birth rates among the majority-Muslim group have dramatically dropped to unprecedented numbers in recent years.
Rushan Abbas, a Uighur activist living in America who spoke to the Associated Press, warned of China’s human rights abuses in detention camps where she suspects her missing sister is right now.
“This is so heartbreaking for us,” Abbas said. “I want people to think about the slavery people are experiencing today. My sister is sitting somewhere being forced to make what, hair pieces?”
In May, CBP made a similar detainment of hair, that time synthetic hair weaves, from a company called Hetian Haolin Hair Accessories Co. Ltd. That company is also located in Xinjiang.
Moreover, the two hair companies have both been placed under CBP Withhold Release Orders, meaning CBP can seize the products for suspected ties to forced labor allowing the producer an opportunity to make their case.
You may like
FDA will work with China to import cancer drugs due to U.S. shortages
Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.
Foreign Desk News writes:
Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.
“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.
Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.
“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.
The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4
— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023
Foreign Desk News adds:
The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.
You may like
Economy4 days ago
New York City Mayor Eric Adams Proposes Housing Asylum Seekers in Private Homes
education7 days ago
Documentary ‘What Is A Woman?’ exposes America’s true history of child exploitation
Economy4 days ago
Texas Gov Abbott aims to eliminate property taxes: ‘we must dream big’
Immigration3 days ago
Biden Administration to allow 40,000 asylum-seekers per month into US with mobile app